GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (STU:S2L) » Definitions » FCF Yield %

Bausch & Lomb (STU:S2L) FCF Yield % : -2.37 (As of May. 29, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Bausch & Lomb's Trailing 12-Month Free Cash Flow is €-120 Mil, and Market Cap is €4,986 Mil. Therefore, Bausch & Lomb's FCF Yield % for today is -2.37%.

The historical rank and industry rank for Bausch & Lomb's FCF Yield % or its related term are showing as below:

STU:S2L' s FCF Yield % Range Over the Past 10 Years
Min: -4.05   Med: 1.72   Max: 9.87
Current: -2.37


During the past 6 years, the highest FCF Yield % of Bausch & Lomb was 9.87%. The lowest was -4.05%. And the median was 1.72%.

STU:S2L's FCF Yield % is ranked better than
51.44% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.78 vs STU:S2L: -2.37

Bausch & Lomb's FCF Margin % for the quarter that ended in Mar. 2024 was -2.37%.


Bausch & Lomb FCF Yield % Historical Data

The historical data trend for Bausch & Lomb's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb FCF Yield % Chart

Bausch & Lomb Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial - - - 3.28 -3.43

Bausch & Lomb Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.24 -3.25 1.22 -4.78 -1.71

Competitive Comparison of Bausch & Lomb's FCF Yield %

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch & Lomb's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's FCF Yield % falls into.



Bausch & Lomb FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bausch & Lomb's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-181.566 / 5298.8014
=-3.43%

Bausch & Lomb's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-23.92 * 4 / 5587.2918
=-1.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bausch & Lomb FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Bausch & Lomb FCF Yield % Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch & Lomb (STU:S2L) Business Description

Traded in Other Exchanges
Address
520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4
Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb (STU:S2L) Headlines

No Headlines